Kyowa Kirin, Inc., a global specialty pharmaceutical company, has announced its extended support of Dream Foundation — the only national dream-granting organization for terminally-ill adults — to fulfill an additional 25 final Dreams in the coming year.
Dream Foundation has given life to more than 30,000 final Dreams over the last 25 years.
Kyowa Kirin’s Commitment to Life, a dedication to improving the quality of life for people around the world, fits with Dream Foundation’s mission to fulfill the final Dreams of terminally-ill adults and their families, a critical part of end-of-life care.
Over the last two years, the two organizations have worked together to bring inspiration, comfort and closure to nearly 25 Dream recipients, which, directly and indirectly, affected hundreds of family members, friends and communities.
Dream recipients can be reunited with family members and loved ones, meet personal heroes, or take trips with their children to store up precious memories.
In addition to making more final dreams come true, the enhanced collaboration will also give U.S.-based Kyowa Kirin employees the opportunity to be directly involved in meeting Dream recipients helping to fulfill their Dreams, bringing their mission to life.
“Our mission to improve the lives of people around the world is central to our culture, and our collaboration with Dream Foundation allows us to live our values in a tangible way within our communities,” said Len Paolillo, Kyowa Kirin’s executive vice president/chief commercial officer.
“Kyowa Kirin’s growing commitment to our mission is wonderful,” said Kisa Heyer, Dream Foundation’s CEO. “We are honored to have the support of the company as a whole and look forward to working closely with their dedicated employees.”
Dream recipients must be at least 18 years old, have a life expectancy of nine months or less, and lack the resources to achieve their Dreams on their own. To apply for a Dream, visit dreamfoundation.org/how-to-apply.
Kyowa Kirin commits to innovative drug discovery driven by state-of-the-art technologies. The company focuses on creating new values in four therapeutic areas: nephrology, oncology, immunology/allergy and neurology. To learn more, visit https://www.kyowakirin.com.
Dream Foundation is supported by a nationwide network of volunteers, hospices, health-care organizations, and committed donors. Dream Foundation receives no state or federal funding; it relies solely on private donations. To support Dream Foundation’s mission, visit DreamFoundation.org/donate.
— Dani Cordaro for Dream Foundation.